Tenax Therapeutics to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

Author's Avatar
Mar 04, 2021
Article's Main Image

Tenax Therapeutics, Inc. (Nasdaq: TENX),a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, today announced that management will present a company overview and hold virtual investor meetings at the H.C. Wainwright Global Life Sciences Virtual Conference being held March 9-10, 2021.